Thermo Fisher Scientific (TMO, Lab tools & research services) Stock Valuation & Fair Value
Trading above its usual valuationThermo Fisher Scientific (TMO, Lab tools & research services) trades at a current P/E of 28.1, about 39% above its historical normal valuation, with a forward growth estimate of 9.8% and a PEG of 2.86. Analysts' one-year estimates have been hit 82% of the time. Priced at its historical normal P/E of 20.2 on the same blended earnings, the 2026-11-13 close of $700.22 corresponds to about $504 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
- Price $700.22 at the Nov 13 close, 0.6% above the 20-day average ($695.77) and 4.4% above the 50-day ($670.56).
- RSI (14) at 53.8.
- 52-week range $437.57 to $721.63: the price is 3.0% below the high and 60.0% above the low.
The Street vs SeerForecast
Wall Street's mean price target for TMO is $752.12 across 25 analysts, 7.4% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: trading above its usual valuation. When the two disagree, start your digging there.
Valuation flags
- Overvalued by 39%
Verdict history
tickerseer's rating changed 4 times after 2026-06-03 and is back where it started: trading above its usual valuation as of 2026-11-09.
Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 47 readings
Frequently asked questions
Is Thermo Fisher Scientific stock overvalued?
At a current P/E of 28.1 versus its historical normal P/E of 20.2, Thermo Fisher Scientific trades about 39% above its typical valuation, with a PEG of 2.86 on 9.8% forward growth. tickerseer currently rates it trading above its usual valuation.
What is Thermo Fisher Scientific's fair value and PEG?
Thermo Fisher Scientific trades at a current P/E of 28.1 against a historical normal P/E of 20.2, a PEG of 2.86, and a forward growth estimate of 9.8%. Priced at its historical normal P/E of 20.2 on the same blended earnings, the 2026-11-13 close of $700.22 corresponds to about $504 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of Thermo Fisher Scientific changed?
tickerseer's rating changed 4 times after 2026-06-03 and is back where it started: trading above its usual valuation as of 2026-11-09.
What is the analyst price target for Thermo Fisher Scientific?
The mean Wall Street price target for Thermo Fisher Scientific is $752.12 across 25 analysts, 7.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Lab tools & research services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.